Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Break dancing on the head may cause a type of scarring hair loss that needs early treatment to prevent permanent damage.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Dermoscopy helps dermatologists diagnose different types of hair loss accurately without always needing a biopsy.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Trichoscopy helps quickly identify autoimmune diseases on the scalp but should be used with other standard tests.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Erdr1 could be a new marker for diagnosing hair loss.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.